Skip to main content

Table 4 PET-CT parameters and EC stage

From: Risk stratification of endometrial cancer and lymph node metastases prediction using 18F-FDG PET/CT: role of metabolic tumor volume and total lesion glycolysis

Parameter Cases (%) SUVmax SUVmean MTV TLG
FIGO stage
IA 15 (45.5%) 12.75 ± 2.23 6.52 ± 1.79 19.95 ± 9.86 132.86 ± 84.91
 > IA 18 (54.5%) 20.77 ± 6.67 9.79 ± 2.89 38.49 ± 15.32 376.48 ± 202.22
P-value   0.0001 0.0006 0.0003 0.0001
95% CI   4.34 to 11.7 1.52 to 5.02 9.172 to 27.908 129.356 to 357.884